Vagus nerve stimulation for pharmacoresistant epilepsy secondary to encephalomalacia: A single-center retrospective study

Vagus nerve stimulation for pharmacoresistant epilepsy secondary to encephalomalacia: A single-center retrospective study

ObjectiveVagus nerve stimulation (VNS) is an adjunctive treatment for pharmacoresistant epilepsy. Encephalomalacia is one of the most common MRI findings in the preoperative evaluation of patients with pharmacoresistant epilepsy. This is the first study that aimed to determine the effectiveness of V...

Full description

Bibliographic Details
Main Authors:	Mengyi Guo, Jing Wang, Zhonghua Xiong, Jiahui Deng, Jing Zhang, Chongyang Tang, Xiangru Kong, Xiongfei Wang, Yuguang Guan, Jian Zhou, Feng Zhai, Guoming Luan, Tianfu Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Neurology
Subjects:	encephalomalacia pharmacoresistant epilepsy vagus nerve stimulation effectiveness predictor
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.1074997/full

Similar Items

Vagus nerve stimulation for refractory posttraumatic epilepsy: Efficacy and predictors of seizure outcome
by: Mengyi Guo, et al.
Published: (2022-07-01)

Surgery for encephalomalacias presenting with intractable epilepsy
by: P. Sarat Chandra, et al.
Published: (2012-01-01)

Effectiveness of vagus nerve stimulation therapy in refractory hypoxic-ischemic encephalopathy-induced epilepsy
by: Mengyi Guo, et al.
Published: (2022-12-01)

Prenatal Diagnosis of Fetal Encephalomalacia after Maternal Diabetic Ketoacidosis
by: Rozalyn Love, et al.
Published: (2014-11-01)

Predictors of pharmacoresistance in adults with epilepsy
by: A. S. Kotov
Published: (2017-02-01)

False pharmacoresistance – a true problem
by: Silvio Bašić, et al.
Published: (2021-01-01)

The differential role of magnetic resonance imaging in predicting surgical outcomes between children versus adults with temporal lobe epilepsy
by: Ke Xu, et al.
Published: (2022-11-01)

Hemispherectomy with corpus callosotomy in pediatric Lennox Gastaut Syndrome associated encephalomalacia cyst: The first case in Indonesia
by: P. I. Gunawan, et al.
Published: (2022-09-01)

The correspondence between morphometric MRI and metabolic profile in Rasmussen’s encephalitis
by: Chongyang Tang, et al.
Published: (2022-01-01)

Editorial: Neuromodulation for pharmacoresistant epilepsy: from bench to bed
by: Tianfu Li, et al.
Published: (2024-02-01)

INCIDENCE OF PHARMACORESISTANT EPILEPSY IN KRASNOYARSK REGION (according to neurological center of university hospital data)
by: N. A. Shnayder, et al.
Published: (2016-08-01)

The clinical and pathological features of low-grade epilepsy-associated glioneuronal tumors
by: Mingguo Xie, et al.
Published: (2022-10-01)

EXPERIENCE WITH USE OF CHRONIC NEUROSTIMULATION OF VAGUS NERVE IN TREATMENT OF PHARMACORESISTANT EPILEPSY
by: А. А. Sufianov, et al.
Published: (2016-09-01)

SEEG‐based reevaluation of epileptogenic networks and the predictive role for reoperation in MTLE patients with surgical failure
by: Ke Xu, et al.
Published: (2023-09-01)

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
by: Gurpreet Kaur Grewal, et al.
Published: (2017-02-01)

Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities
by: Fan Chen, et al.
Published: (2019-02-01)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
by: Gianluca Dini, et al.
Published: (2022-05-01)

Protocol of a prospective multicenter randomized controlled trial of robot-assisted stereotactic lesioning in the treatment of focal drug-resistant epilepsy
by: Mingkun Gong, et al.
Published: (2023-06-01)

Super-refractory status epilepticus and pharmacoresistant epilepsy in an infant with hemorrhagic shock and encephalopathy syndrome
by: Kravljanac Ružica, et al.
Published: (2021-01-01)

USING BAYESIAN METHODS IN THE TASK OF MODELING THE PATIENTS' PHARMACORESISTANCE DEVELOPMENT
by: Mariia A. Voronenko, et al.
Published: (2022-06-01)

Delayed effect of VNS on interictal epileptiform discharges and pharmacoresistance in a patient with refractory perinatal postischemic epilepsy
by: Davor Sporiš, et al.
Published: (2021-01-01)

Multicystic encephalomalacia and gastrointestinal injury following single fetal death in first trimester and subsequent fetofetal transfusion syndrome in a monochorionic triplet pregnancy: a case report
by: Po Lam So, et al.
Published: (2019-08-01)

Seizure outcomes and prognostic factors in patients with gangliogliomas associated with epilepsy
by: Yue Hu, et al.
Published: (2022-08-01)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
by: Gianluca Dini, et al.
Published: (2023-01-01)

Occipital Lobe Epilepsy With Ictal Fear: Evidence From a Stereo-Electroencephalography (sEEG) Case
by: Jing Wang, et al.
Published: (2018-08-01)

Pharmacoresistant neuropathic pain: Role of proper assessment in the understanding and tactics of correction
by: Maksim Valeryevich Churyukanov, et al.
Published: (2013-11-01)

KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy
by: Jodi L. Smith, et al.
Published: (2024-01-01)

Correlation Between Ictal Signs and Anatomical Subgroups in Temporal Lobe Seizures: A Stereoelectroencephalography Study
by: Bo Zhang, et al.
Published: (2022-06-01)

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy
by: El-Tallawy HN, et al.
Published: (2021-09-01)

Efficacy and safety of using vagus nerve stimulation in patients with pharmacoresistant epilepsy in the Russian Federation: a multi-center retrospective observational program
by: K. V. Voronkova, et al.
Published: (2021-07-01)

Low-grade epilepsy-associated neuroepithelial tumors: Tumor spectrum and diagnosis based on genetic alterations
by: Mingguo Xie, et al.
Published: (2023-01-01)

Dynamic Correlations between Intrinsic Connectivity and Extrinsic Connectivity of the Auditory Cortex in Humans
by: Zhuang Cui, et al.
Published: (2017-08-01)

Magnetoencephalography STOUT Method Adapted to Radiofrequency Thermocoagulation for MR-Negative Insular Epilepsy: A Case Report
by: Kaiqiang Ma, et al.
Published: (2021-10-01)

MDR1 Gene C3435T and C1236T Polymorphisms among Patients with Pharmacoresistant Epilepsy and Healthy Individuals
by: Nodira M. Tuychibaeva, et al.
Published: (2014-12-01)

Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome; A Pilot Study
by: Narong eAuvichayapat, et al.
Published: (2016-05-01)

Serum levels of oxidative stress biomarkers is changed in pharmacoresistant mesial temporal lobe epilepsy patients with or without psychiatric disorders
by: Angélica Marta Lopes, et al.
Published: (2023-09-01)

Cognitive Processing Impacts High Frequency Intracranial EEG Activity of Human Hippocampus in Patients With Pharmacoresistant Focal Epilepsy
by: Jan Cimbalnik, et al.
Published: (2020-10-01)

THE USE OF THE PRINCIPLE OF VESTIBULAR NEUROMODULATION IN COMPLEX TREATMENT OF PHARMACORESISTENT DEPRESSION (clinical observation)
by: A. G. Naryshkin, et al.
Published: (2019-04-01)

Distinguishing Dependent-Stage Secondary Epileptogenesis in a Complex Case of Giant Hypothalamic Hamartoma With Assistance of a Computational Method
by: Zhao Liu, et al.
Published: (2020-06-01)

Predictors of seizure outcomes in stereo-electroencephalography-guided radio-frequency thermocoagulation for MRI-negative epilepsy
by: Qi Huang, et al.
Published: (2024-03-01)